As RNA therapeutics become more prevalent we will require more robust and reliable methods for their QC/QA. New work from the Mercer Lab shows that nanopore sequencing can be quite useful for quantifying homogeneity of mRNA therapeutics!

https://www.nature.com/articles/s41467-023-41354-y#Ack1